Glassy cell carcinoma of the cervix - Cytologic features and expression of estrogen receptor, progesterone receptor and Her2/neu protein

被引:10
|
作者
Kuroda, Hajime [1 ]
Toyozumi, Yasuo [1 ]
Masuda, Tomoko [1 ]
Ougida, Tomohiko [1 ]
Hanami, Kyota [1 ]
Kyoko, Kiuchi [1 ]
Tamaru, Jun-ichi [1 ]
Itoyama, Shinji [1 ]
机构
[1] Saitama Med Sch, Saitama Med Ctr, Dept Pathol, Kawagoe, Saitama 3508550, Japan
关键词
cervical cancer; estrogen; progesterone; Her2/neu protein; glassy cell carcinoma;
D O I
10.1159/000325985
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective To analyze the cytologic features, estrogen and progesterone receptors, and Her2/neu protein in glassy cell carcinoma (GCC) of the cervix. Study Design Cases were analyzed using various parameters, including age at presentation, stage, treatment and clinical course. Between 1990 and 2003, patients with primary cervical carcinomas were treated and cytopathologic analyses performed. Tests for estrogen receptor (ER), progesterone receptor (PR) and her2/neu protein were performed on paraffin sections. Results GCC of the cervix is composed of large cells with abundant chromatin, which gives them their characteristic glassy appearance. Eleven cases were identified as GCC. One case (9.1%) was correctly diagnosed from the cervicovaginal smear. Among the GCC cases, ER. PR and Her2/neu were positive in 2(18.1%), 1 (9.1%) and 5(45.4%) cases, respectively. Conclusion Cytology of GCC reveals characteristic features that differ from those of other carcinomas of the cervix. GCC has unique cytologic characteristics and causes diagnostic confusion, possibly leading to incorrect diagnoses. The reason for such low diagnostic precision in cytology might be due to the lack of differentation and low frequency of this tumor. Our results, demonstrating Her2/neu overexpression, may correlate with more aggressive behavior and a worse clinical outcome.
引用
收藏
页码:418 / 422
页数:5
相关论文
共 50 条
  • [21] Her2/neu expression in breast cancer patients who have a combination of low grade progesterone receptor with high grade estrogen receptor status
    Karseladze, D.
    Chemeris, G.
    Byakhova, M.
    VIRCHOWS ARCHIV, 2016, 469 : S51 - S51
  • [22] Estrogen and progesterone receptor status, p53 and Her-2/neu protein expression in metachronous bilateral breast carcinoma (MBBC)
    Vrcel, V
    Brogi, E
    Cranor, ML
    Son, T
    Hudis, C
    Norton, L
    Tan, LK
    MODERN PATHOLOGY, 2002, 15 (01) : 55A - 55A
  • [23] Expression of estrogen receptor, progesterone receptor, and Her-2/neu in primary and extra-corporeal endometrial cancer
    Tangjitgamol, Siriwan
    Tanvanich, Sujitra
    Srijaipracharoen, Sunamchok
    Manusirivithaya, Sumonmal
    HISTOLOGY AND HISTOPATHOLOGY, 2013, 28 (06) : 787 - 794
  • [24] Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma
    Kumar, K. S.
    Gupta, N.
    Rajwanshi, A.
    Joshi, K.
    Singh, G.
    CYTOPATHOLOGY, 2012, 23 (03) : 181 - 186
  • [25] Progesterone receptor status in determining the prognosis of estrogen receptor positive/HER2 negative breast carcinoma patients
    Bal, Oznur
    Arslan, Ulku Yalcintas
    Durnali, Ayse
    Uyetrk, Ummugul
    Demirci, Ayse
    Tastekin, Didem
    Ekinci, Ahmet
    Esbah, Onur
    Turker, Ibrahim
    Sonmez, Ozlem Uysal
    Oksuzoglu, Berna
    JOURNAL OF BUON, 2015, 20 (01): : 28 - 34
  • [26] Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study
    Tangjitgamol, S
    Ramirez, PT
    Sun, CC
    See, HT
    Jhingran, A
    Kavanagh, JJ
    Deavers, MT
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (04) : 646 - 656
  • [27] Overexpression of her2/neu, estrogen and progesterone receptors in invasive micropapillary carcinoma of the breast
    Kuroda H.
    Sakamoto G.
    Ohnisi K.
    Itoyama S.
    Breast Cancer, 2004, 11 (3) : 301 - 305
  • [28] Breast cancer histological grade is associated with estrogen receptor (ER), progesterone receptor (PR), and HER2 expression
    Suzuki, M.
    Kimijima, I.
    Watanabe, K.
    EJC SUPPLEMENTS, 2008, 6 (07): : 102 - 102
  • [29] Expression of COX-2 and HER-2/neu and estrogen and progesterone receptor in primary squamous cell carcinomas of the endometrium
    L.-C. Horn
    S. Faber
    K. Bilek
    C. Leo
    Journal of Cancer Research and Clinical Oncology, 2005, 131 : 226 - 228
  • [30] Expression of COX-2 and HER-2/neu and estrogen and progesterone receptor in primary squamous cell carcinomas of the endometrium
    Horn, LC
    Faber, S
    Bilek, K
    Leo, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (04) : 226 - 228